TIDMBATS
RNS Number : 9930P
British American Tobacco PLC
13 October 2023
British American Tobacco p.l.c. (the "Company")
13 October 2023
BAT Appoints Chief People Officer to the Management Board
Further to the changes to the Management Board announced on 19
June 2023, Cora Koppe-Stahrenberg, has been appointed to the new
role of Chief People Officer and will join the BAT Management Board
with effect from 1 November 2023.
Bringing critical experiences from other sectors and industries,
Cora was most recently Global Head of Human Resources of Fresenius
Medical Care, a publicly listed global healthcare company with over
125,000 employees. While at Fresenius Medical Care, Cora
established a new Global HR function, and implemented a global
people strategy which focused on the creation of a collaborative
and empowering culture delivered through a number of change
initiatives. Previously, Cora held various international senior HR
positions at Marsh & McLennan Companies, Emirates Investment
Authority, and General Electric.
Tadeu Marroco, Chief Executive , commented:
"I am delighted to welcome Cora to the Management Board. This is
a significant management team enhancing appointment for BAT.
Culture and collaboration are at the heart of my leadership agenda,
Cora shares these values and will play a key role in the Group's
transformation to build A Better Tomorrow. I have no doubt that
Cora will bring a fresh perspective having worked internationally
in multiple sectors outside our industry and will bring new
insights and capability to our management team.
"I look forward to working with Cora to deliver a winning
culture and a dynamic, modern BAT."
The Chief People Officer will report to the Chief Executive.
ENDS
Enquiries
Media Centre
+44 (0) 20 7845 2888 (24 hours) | @BATplc
Investor Relations
Victoria Buxton: +44 (0)20 7845 2012
Amy Chamberlain: +44 (0)20 7845 1124
Yetunde Ibe: +44 (0)20 7845 1095
John Harney: +44 (0)20 7845 1263
Jane Henderson: +44 (0)20 7845 1117
About BAT
BAT is a leading, multi-category consumer goods business with a
purpose to build A Better Tomorrow(TM) by reducing the health
impact of its business through offering a greater choice of
enjoyable and less risky products for adult consumers.
We continue to be clear that combustible cigarettes pose serious
health risks, and the only way to avoid these risks is not to start
or to quit. BAT encourages those who would otherwise continue to
smoke to switch completely to scientifically-substantiated,
reduced-risk alternatives* . In order to deliver this, BAT is
transforming into a truly consumer-centric multi-category consumer
products business.
BAT's ambition is to have 50 million consumers of its
non-combustible products by 2030 and to generate GBP5billion of New
Categories revenue by 2025. BAT has set stretching ESG targets
including achieving carbon neutrality for Scopes 1 & 2 by 2030
and eliminating unnecessary single-use plastic and making all
plastic packaging reusable, recyclable or compostable by 2025.
BAT employs over 50,000 people. The BAT Group generated revenue
of GBP27.65 billion in 2022 and profit from operations of GBP10.5
billion.
The company's Strategic Portfolio is made up of its global
cigarette brands and a growing range of reduced-risk* New Category
tobacco and nicotine products and traditional non-combustible
tobacco products. These include vapour, tobacco heating products,
modern oral products including tobacco-free nicotine pouches, as
well as traditional oral products such as snus and moist snuff. In
2022, we had 22.5 million consumers of our non-combustible
products, a rise of 4.2 million on full year 2021.
References in this statement to 'BAT', 'we', 'us' and 'our'
refer to the British American Tobacco Group.
* Based on the weight of evidence and assuming a complete switch
from cigarette smoking. These products are not risk free and are
addictive.
Our vapour product Vuse (including Alto, Solo, Ciro and Vibe),
and certain products, including Velo, Grizzly, Kodiak, and Camel
Snus, which are sold in the U.S., are subject to FDA regulation and
no reduced-risk claims will be made as to these products without
agency clearance.
Forward-looking statements
This release contains certain forward-looking statements,
including "forward-looking" statements made within the meaning of
the U.S. Private Securities Litigation Reform Act of 1995. These
statements are often, but not always, made through the use of words
or phrases such as "believe," "anticipate," "could," "may,"
"would," "should," "intend," "plan," "potential," "predict,"
"will," "expect," "estimate," "project," "positioned," "strategy,"
"outlook", "target" and similar expressions. These include
statements regarding our customer target ambition, New Categories
revenue targets and our ESG targets.
All such forward-looking statements involve estimates and
assumptions that are subject to risks, uncertainties and other
factors. It is believed that the expectations reflected in this
release are reasonable but they may be affected by a wide range of
variables that could cause actual results to differ materially from
those currently anticipated. A review of the reasons why actual
results and developments may differ materially from the
expectations disclosed or implied within forward-looking statements
can be found by referring to the information contained under the
headings "Cautionary Statement" and "Group Principal Risks" in the
2022 Annual Report and Form 20-F of British American Tobacco p.l.c.
(BAT PLC).
Additional information concerning these and other factors can be
found in BAT PLC's filings with the U.S. Securities and Exchange
Commission ("SEC"), including the Annual Report on Form 20-F and
Current Reports on Form 6-K, which may be obtained free of charge
at the SEC's website, http://www.sec.gov and BAT PLC's Annual
Reports, which may be obtained free of charge from the BAT website
www.bat.com .
Past performance is no guide to future performance and persons
needing advice should consult an independent financial adviser. The
forward-looking statements reflect knowledge and information
available at the date of preparation of this release and BAT
undertakes no obligation to update or revise these forward-looking
statements, whether as a result of new information, future events
or otherwise. Readers are cautioned not to place undue reliance on
such forward-looking statements.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAFLFFDIVLFLIV
(END) Dow Jones Newswires
October 13, 2023 02:00 ET (06:00 GMT)
British American Tobacco (LSE:0A76)
過去 株価チャート
から 5 2024 まで 6 2024
British American Tobacco (LSE:0A76)
過去 株価チャート
から 6 2023 まで 6 2024